The Chinese hamster FANCG/XRCC9 mutant NM3 fails to express the monoubiquitinated form of the FANCD2 protein, is hypersensitive to a range of DNA damaging agents and exhibits a normal level of spontaneous sister chromatid exchange

Carcinogenesis

Volumn 22, Issue 12, 2001, Pages 1939-1946

  Wilson, James B ^a   Johnson, Mark A ^a   Stuckert, Anna P ^b   Trueman, Kelly L ^a   May, Simon ^a   Bryant, Peter E ^c   Meyn, Raymond E ^d   D'Andrea, Alan D ^b   Jones, Nigel J ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF ST ANDREWS   (United Kingdom)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; BRCA1 PROTEIN; BUTADIENE DIEPOXIDE; CAMPTOTHECIN; CHLORAMBUCIL; CHLORMETHINE; COMPLEMENTARY DNA; DNA; ETOPOSIDE; ISOPROTEIN; MELPHALAN; MITOMYCIN C; NUCLEAR PROTEIN; RUFOCROMOMYCIN;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CELL MUTANT; CHO CELL; CONTROLLED STUDY; DNA CROSS LINKING; DNA DAMAGE; DNA STRAND BREAKAGE; DRUG SENSITIVITY; FANCONI ANEMIA; GENE ACTIVATION; GENETIC COMPLEMENTATION; GENETIC STABILITY; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PROTEIN INTERACTION; SISTER CHROMATID EXCHANGE;

EID: 0035688468     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/22.12.1939     Document Type: Article

References (63)

1. Fanconi-anemia and its variability
2. Fanconi's anemia and malignancies
3. Molecular biology of Fanconi anemia. Implications for diagnosis and therapy
4. Fanconi anemia diagnosis and the diepoxybutane (DEB) test
5. Survey of radiosensitivity in a variety of human cell strains
6. Response of human fibroblasts to low dose-rate gamma irradiation
7. Effects of ionising-radiation on cells from Fanconi's anemia patients
8. Drug sensitivity spectra in Fanconi anemia lymphoblastoid cell lines of defined complementation groups
9. Evidence for at least eight Fanconi anemia genes
10. Complementation analysis in Fanconi anemia: Assignment of the reference FA-H patient to group A
11. Positional cloning of a novel Fanconi anemia gene, FANCD2
12. Cloning of cDNAs for Fanconi anemia by functional complementation
13. Expression cloning of a cDNA for the major Fanconi anemia gene, FAA
14. Positional cloning of the Fanconi anemia group A gene
15. The Fanconi anemia group G gene FANCG is identical with XRCC9
16. Isolation of a cDNA representing the Fanconi anemia complementation group E gene
17. The Fanconi anemia gene FANCF encodes a novel protein with homology to ROM
18. A CHO mutant, UV40, that is sensitive to diverse mutagens and represents a new complementation group of mitomycin C sensitivity
19. Cloning and characterization of the human XRCC9 gene, which corrects chromosomal instability and mutagen sensitivity in CHO UV40 cells
20. Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex
21. A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA
22. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG
23. Direct interactions of the five known Fanconi anemia proteins suggest a common functional pathway
24. The Fanconi anemia pathway requires FAA phosphorylation and FAA/FAC nuclear accumulation
25. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway
26. Chinese hamster cells meet DNA repair: An entirely acceptable affair
27. Mammalian X-ray sensitive mutants: A tool for the elucidation of the cellular response to ionizing radiation
28. XRCC2 and XRCC3, new human Rad51-family members, promote chromosome stability and protect against DNA cross-links and other damages
29. Correction of chromosomal instability and sensitivity to diverse mutagens by a cloned cDNA of the XRCC3 DNA repair gene
30. Mammalian XRCC2 promotes the repair of DNA double-strand breaks by homologous recombination
31. Genetic diversity of mitomycin C hyper-sensitive Chinese-hamster cell mutants - A new complementation group with chromosomal instability
32. A new complementation group of mitomycin C-hypersensitive Chinese hamster cell mutants that closely resembles the phenotype of Fanconi anemia cells
33. Biochemical and genetic analysis of the Chinese hamster mutants irs1 and irs2 and their comparison to cultured ataxia telangiectasia cells
34. Genetic analysis of mitomycin C hypersensitive Chinese hamster cell mutants
35. Cellular and chromosomal hypersensitivity to DNA cross-linking agents and topoisomerase inhibitors in the radiosensitive Chinese-hamster irs mutants - Phenotypic similarities to ataxia-telangiectasia and Fanconi's anemia cells
36. The Chinese hamster cell mutant V-H4 is homologous to Fanconi anemia (complementation group-A)
37. Isolation and characterization of nitrogen mustard-sensitive mutants of Chinese hamster ovary cells
38. A screening method for isolating DNA repair deficient mutants of CHO cells
39. Isolation and cross-sensitivity of X-ray-sensitive mutants of V79-4 hamster-cells
40. The isolation and genetic analysis of V79-derived etoposide sensitive Chinese hamster cell mutants: Two new complementation groups of etoposide sensitive mutants
41. Isolation of camptothecin sensitive Chinese hamster cell mutants: Phenotypic heterogeneity within the ataxia telangiectasia-like XRCC8 (irs2) complementation group
42. Phenotype of FAECB (Facility for Automated Experiments in Cell Biology) Chinese hamster ovary mutants with minimal UV sensitivity
43. 6 complementation groups for ionizing radiation sensitivity in Chinese hamster cells
44. Resistance to methyl mercaptopurine riboside in cultured hamster cells. Preliminary characterisation of resistant cells and conditions affecting their selection in quantitative mutation studies
45. New Giemsa method for the differential staining of sister chromatids
46. Phenotypic characterisation of MC5, a unique mitomycin C-hypersensitive Chinese hamster cell mutant
47. The genetic basis of resistance to ionizing radiation damage in cultured mammalian cells
48. Mitomycin C - Small, fast and deadly (but very selective)
49. A review of the genetic and related effects of 1,3-butadiene in rodents and humans
50. DNA damage and mutagenesis by radiomimetic DNA-cleaving agents: Bleomycin, neocarzinostatin and other enediynes
51. Role of NAD(P)H:quinone oxidoreductase (DT-diaphorase) in cytotoxicity and induction of DNA damage by streptonigrin
52. Camptothecin cytotoxicity in mammalian cells is associated with the induction of persistent double-strand breaks in replicating DNA
53. DNA double-strand break repair pathways and cellular tolerance to inhibitors of topoisomerase II
54. The response of a variety of human fibroblast cell strains to the lethal effects of alkylating agents
55. Susceptibility of Fanconi's anemia lymphoblasts to DNA cross-linking and alkylating-agents
56. Phenotypic correction of Fanconi anemia group C knockout mice
57. Abnormal rearrangements associated with V(D)J recombination in Fanconi anemia
58. The Fanconi anemia proteins FANCA and FANCG stabilize each other and promote the nuclear accumulation of the Fanconi anemia complex
59. Carboxy terminal region of the Fanconi anemia protein, FANCG/XRCC9, is required for functional activity
60. Association of complementation group and mutation type with clinical outcome in Fanconi anemia
61. Spectrum of mutations in the Fanconi anemia group G gene
62. Fanconi anemia protein, FANCG, is a phosphoprotein and is upregulated with FANCA after TNF-alpha treatment
63. Cytogenetic characterisation of the ionizing radiation-sensitive Chinese hamster mutant irs1